TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Est. Return
18.15%
This Fund
S&P 500
1 Year Est. Return
+18.15%
AUM
$2.63B
AUM Growth
-$21.2M
(-0.8%)
Holding
190
Top Buys
| 1 | +$47.3M | |
| 2 | +$18.8M | |
| 3 | +$18M | |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$16.7M |
| 5 |
Pfizer
PFE
|
+$13.7M |
Top Sells
| 1 | +$47.2M | |
| 2 | +$24.6M | |
| 3 | +$24M | |
| 4 |
Humana
HUM
|
+$20.2M |
| 5 |
UnitedHealth
UNH
|
+$17.6M |
Sector Composition
| 1 | Healthcare | 96.54% |
| 2 | Real Estate | 2.01% |
| 3 | Industrials | 0.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLCM
176
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $1.98K | ﹤0.01% |
6,000
|
|
||
177
Arvinas
ARVN
$779M
| – | – |
-42,998
|
|
||
178
HealthEquity
HQY
$6.65B
| – | – |
-110,214
|
|
||
179
IDEAYA Biosciences
IDYA
$2.91B
| – | – |
-133,185
|
|
||
180
MoonLake Immunotherapeutics
MLTX
$1.23B
| – | – |
-300,000
|
|
||
181
Xencor
XNCR
$880M
| – | – |
-200,328
|
|
||
|
MORF
182
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| – | – |
-44,625
|
|
||
|
ALR
183
DELISTED
AlerisLife Inc
ALR
| – | – |
-24,237
|
|
||
|
ONEM
184
DELISTED
1Life Healthcare
ONEM
| – | – |
-31,266
|
|
||
|
HZNP
185
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| – | – |
-415,053
|
|
||
186
Pliant Therapeutics
PLRX
$83M
| – | – |
-35,233
|
|
||
187
Protagonist Therapeutics
PTGX
$5.89B
| – | – |
-122,271
|
|
||
188
Stevanato
STVN
$4.09B
| – | – |
-71,190
|
|
||
189
Acadia Pharmaceuticals
ACAD
$3.51B
| – | – |
-72,225
|
|